You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

BENZOYL PEROXIDE; TRETINOIN - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for benzoyl peroxide; tretinoin and what is the scope of freedom to operate?

Benzoyl peroxide; tretinoin is the generic ingredient in one branded drug marketed by Galderma Labs Lp and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Benzoyl peroxide; tretinoin has sixty-three patent family members in thirteen countries.

One supplier is listed for this compound.

Summary for BENZOYL PEROXIDE; TRETINOIN
International Patents:63
US Patents:7
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Clinical Trials: 9
DailyMed Link:BENZOYL PEROXIDE; TRETINOIN at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for BENZOYL PEROXIDE; TRETINOIN
Generic Entry Date for BENZOYL PEROXIDE; TRETINOIN*:
Constraining patent/regulatory exclusivity:
Dosage:
CREAM;TOPICAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for BENZOYL PEROXIDE; TRETINOIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GWT-TUD GmbHPhase 4
Galderma Laboratories, L.P.Phase 4
Zeichner, Joshua, M.D.Phase 4

See all BENZOYL PEROXIDE; TRETINOIN clinical trials

Pharmacology for BENZOYL PEROXIDE; TRETINOIN
Drug ClassRetinoid

US Patents and Regulatory Information for BENZOYL PEROXIDE; TRETINOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp TWYNEO benzoyl peroxide; tretinoin CREAM;TOPICAL 214902-001 Jul 26, 2021 RX Yes Yes 12,070,629 ⤷  Subscribe Y ⤷  Subscribe
Galderma Labs Lp TWYNEO benzoyl peroxide; tretinoin CREAM;TOPICAL 214902-001 Jul 26, 2021 RX Yes Yes 12,053,546 ⤷  Subscribe Y ⤷  Subscribe
Galderma Labs Lp TWYNEO benzoyl peroxide; tretinoin CREAM;TOPICAL 214902-001 Jul 26, 2021 RX Yes Yes 9,868,103 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for BENZOYL PEROXIDE; TRETINOIN

Country Patent Number Title Estimated Expiration
Eurasian Patent Organization 201200347 ⤷  Subscribe
Australia 2006274541 Metal oxide coating of water insoluble ingredients ⤷  Subscribe
Eurasian Patent Organization 200970724 КОМПОЗИЦИИ ДЛЯ МЕСТНОГО ПРИМЕНЕНИЯ, СОДЕРЖАЩИЕ ПЕРОКСИД И РЕТИНОИД ⤷  Subscribe
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for BENZOYL PEROXIDE; TRETINOIN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1586316 SPC/GB11/054 United Kingdom ⤷  Subscribe PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523
0591275 SPC/GB05/030 United Kingdom ⤷  Subscribe PRODUCT NAME: NITISINONE (2-(2-NITRO-4-TRIFLUOROMETHYLBENZOYL)-1,3-CYCLOHEXANEDIONE) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/04/303/001 20050221; UK EU/1/04/303/002 20050221; UK EU/1/04/303/003 20050221
1458369 CA 2008 00029 Denmark ⤷  Subscribe PRODUCT NAME: ADAPALEN, BENZOYLPEROXID
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

BENZOYL PEROXIDE; TRETINOIN Market Analysis and Financial Projection Experimental

Benzoyl Peroxide and Tretinoin: Market Dynamics and Financial Trajectory

Introduction

Benzoyl peroxide and tretinoin are two widely used dermatological treatments, particularly for acne and other skin conditions. Understanding their market dynamics and financial trajectories is crucial for stakeholders in the pharmaceutical and skincare industries.

Benzoyl Peroxide Market Overview

Market Size and Growth

The benzoyl peroxide market is projected to reach $462.5 million by 2030, growing at a CAGR of 3.56% during the 2024-2030 period. This growth is driven by its versatile applications, including its use in the pharmaceutical sector, particularly for treating acne[1].

Key Applications

  • Pharmaceutical Sector: Benzoyl peroxide is primarily used in the treatment of acne due to its efficacy in reducing acne-causing bacteria.
  • Industrial Applications: It is widely used in the chemical and plastics industry as a polymerization initiator, bleaching agent, and cross-linking agent. The industrial grade segment holds the largest market share, driven by its use in paints, coatings, and adhesives[1].

Geographic Distribution

  • North America: This region witnessed the highest growth in the benzoyl peroxide market, with a market share of 32% in 2023. The demand is driven by its use in processed food items and skincare products[1].

Tretinoin Market Overview

Market Size and Growth

The tretinoin market was valued at $2.5 billion in 2024 and is projected to reach $7.5 billion by 2031, growing at a CAGR of 10.1% during the forecast period. This significant growth is attributed to the expanding beauty and cosmetics sector, particularly in skincare products[3].

Key Applications

  • Skincare Products: Tretinoin is known for its skin-renewing and anti-aging properties, making it a frequent ingredient in skincare formulations.
  • Dermatological Treatments: It is prescribed for various dermatological conditions, including acne and other skin issues. The demand is driven by the preference for topical treatments and recommendations from dermatologists[3].

Geographic Distribution

  • North America: This region is a significant market for tretinoin, along with Europe and the Asia-Pacific, where the skincare market is growing rapidly[3].

Market Drivers

Growing Skincare Industry

Both benzoyl peroxide and tretinoin benefit from the growing skincare industry. The increasing global concern about skincare and the demand for effective solutions for acne and other skin issues drive the market forward[1][3].

Demographic Factors

  • Acne Prevalence: The escalating number of acne cases, influenced by genetics, sensitive skin, stressful lifestyles, and increasing obesity rates, particularly in North America, contributes to the growing demand for these treatments[1].
  • Aging Population: The anti-aging properties of tretinoin make it popular among an aging population seeking skincare solutions[3].

Technological Advancements

  • Proprietary Technologies: Innovations such as Sol-Gel Technologies' proprietary technology to encapsulate benzoyl peroxide within silica-based microcapsules enhance the efficacy and safety profile of these treatments. This technology is used in products like EPSOLAY, which treats inflammatory lesions of rosacea[2][5].

Financial Trajectory

Revenue and Growth

  • Benzoyl Peroxide: The market is expected to grow steadily, driven by its industrial and pharmaceutical applications. The industrial grade segment's dominance and the growing demand in the North American region are key financial drivers[1].
  • Tretinoin: The market is experiencing robust growth, with a CAGR of 10.1% from 2024 to 2031. This growth is fueled by the increasing demand for skincare products and the expanding beauty and cosmetics sector[3].

Company Performance

  • Sol-Gel Technologies: This company has seen significant growth in its dermatology products, including EPSOLAY and TWYNEO, which contain benzoyl peroxide and other active ingredients. The company's revenue from these products, received from its commercial partner Galderma, indicates a strong financial trajectory. As of 2022, Sol-Gel had a cash balance of $35.3 million, which is expected to fund operational and capital expenditures through the first quarter of 2024[2][5].

Competitive Landscape

Market Share Analysis

  • Benzoyl Peroxide: The industrial grade segment dominates the market, with a significant share driven by its versatile applications in the chemical and plastics industry[1].
  • Tretinoin: The market is competitive, with various players offering tretinoin-based products. Dermatologists' recommendations and patient preference for topical treatments are key factors influencing market share[3].

Distribution Channels

Benzoyl Peroxide

  • Pharmaceuticals: Available in skincare products and pharmaceutical formulations.
  • Industrial: Supplied to various industries such as paints, coatings, and adhesives[1].

Tretinoin

  • Pharmacies and Drugstores: Over-the-counter and prescription-based products.
  • Online Retail: Available through e-commerce platforms, contributing to its growing market presence[3].

Key Takeaways

  • Growing Demand: Both benzoyl peroxide and tretinoin are experiencing growing demand driven by the skincare industry and demographic factors.
  • Technological Innovations: Proprietary technologies are enhancing the efficacy and safety of these treatments.
  • Financial Growth: The markets for both compounds are projected to grow significantly, with benzoyl peroxide reaching $462.5 million by 2030 and tretinoin reaching $7.5 billion by 2031.
  • Geographic Distribution: North America is a key market for both compounds, with significant growth also expected in other regions.

FAQs

What are the primary applications of benzoyl peroxide?

Benzoyl peroxide is primarily used in the pharmaceutical sector for treating acne and in the chemical and plastics industry as a polymerization initiator, bleaching agent, and cross-linking agent[1].

How is the tretinoin market expected to grow?

The tretinoin market is projected to grow at a CAGR of 10.1% from 2024 to 2031, reaching $7.5 billion by 2031, driven by the expanding beauty and cosmetics sector[3].

What technological advancements are enhancing the efficacy of benzoyl peroxide treatments?

Sol-Gel Technologies' proprietary technology to encapsulate benzoyl peroxide within silica-based microcapsules is a significant advancement, enhancing the efficacy and safety profile of treatments like EPSOLAY[2][5].

Which regions are driving the growth of the benzoyl peroxide market?

North America is witnessing the highest growth in the benzoyl peroxide market, driven by its use in processed food items and skincare products[1].

How does the competitive landscape look for tretinoin-based products?

The market is competitive, with various players offering tretinoin-based products. Dermatologists' recommendations and patient preference for topical treatments are key factors influencing market share[3].

Sources

  1. IndustryARC, "Benzoyl Peroxide Market - Forecast(2021-2026) Research Report"
  2. GlobeNewswire, "Sol-Gel Technologies Reports Third Quarter 2022 Financial Results and Provides Corporate Update"
  3. Verified Market Research, "Tretinoin Market Size, Share, Scope, Trends And Forecast"
  4. Fortune Business Insights, "U.S. Acne Treatment Market Size, Share | Growth Report [2030]"
  5. Sol-Gel Technologies, "Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.